Clinical Trials Directory

Trials / Completed

CompletedNCT04472039

Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Vienna Institute for Research in Ocular Surgery · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Aim of the study is to assess the rate of postoperative intraretinal cystoid changes after pars plana vitrectomy with membrane peeling and peribulbar application of triamcinolone acetonide and to examine possible risk factors for postoperative intraretinal cystoid changes.

Detailed description

Epiretinal membranes (ERM) are disorders leading to vision loss and metamorphopsia. Vitrectomy with membrane peeling has developed to be the gold-standard in treatment of ERM. Nevertheless, there are about 10% of patients having intraretinal cystoid changes after surgery with potential for disturbance of visual acuity. The aim of the study is to assess the rate of postoperative intraretinal cystoid changes after pars plana vitrectomy with membrane peeling and peribulbar application of triamcinolone acetonide and to examine possible risk factors for postoperative intraretinal cystoid changes.

Conditions

Interventions

TypeNameDescription
DEVICEoptical coherence tomography (OCT)OCT visualizes the retinal layers by backreflection of light

Timeline

Start date
2020-06-30
Primary completion
2020-09-28
Completion
2020-09-28
First posted
2020-07-15
Last updated
2020-09-29

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT04472039. Inclusion in this directory is not an endorsement.